FTCM
SONM icon

First Trust Capital Management’s DNA X Inc SONM Stock Holding History

First Trust Capital Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-208
Closed -$1.36M – 43
2019
Q4 		$1.36M Buy
208
+133
+177% +$656K 0.43% 20
2019
Q3 		$397K Buy
+75
New +$1.15M 0.13% 34

Other funds holding SONM

NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PA Capital Richmond, Virginia $142M AUM 46.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

First Trust Capital Management's SONM Position: Q1 2020 in Review

First Trust Capital Management sold out of DNA X Inc (SONM) in Q1 2020, closing a stake of 208 shares — an estimated $1.36M sold.

First Trust Capital Management first reported a position in SONM in Q3 2019 and held it in 2 quarters. The position peaked at $1.36M in Q4 2019. 37 funds tracked by Wall St. Rank hold SONM as of Q1 2020.

  • First Trust Capital Management reported no remaining DNA X Inc position as of Q1 2020 after selling out during the quarter.
  • First Trust Capital Management sold 208 DNA X Inc shares in Q1 2020, an estimated $1.36M.
  • First Trust Capital Management first reported a position in DNA X Inc in Q3 2019 and held it in 2 quarters.
  • First Trust Capital Management's DNA X Inc position peaked at $1.36M in Q4 2019.
  • 37 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2020.

Based on First Trust Capital Management's 13F filing for Q1 2020, filed 15 May 2020.